Vicapsys Life Sciences, Inc.
VICP · OTCMCIK 1468639fmd_0QBJS5HANR6VBAC2Z21XPWDR3GManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2019 to Sep 30, 2024, 23 periods
| Line item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|
| Research and development | 0 | 0 | 0 | 0 | 0 |
| Total operating expenses | 1 | 1 | 0 | 1 | 1 |
| Operating income | – | (1) | (0) | (1) | (1) |
| Interest expense | – | – | – | – | 0 |
| Other non-operating income (expense) | – | – | 0 | – | (0) |
| Income before taxes | (1) | (1) | (0) | (1) | (1) |
| Net income from continuing operations | (1) | (1) | – | – | – |
| Net income | (1) | (1) | (0) | (1) | (1) |
| Net income to common shareholders | (2) | (1) | (0) | (1) | (1) |